Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen

Tools and advanced imaging technologies for assessing intestinal epithelial barrier integrity: a systematic review (2026) Vieujean S, Atreya R, Buda A, Caradec J, Citi S, Danese S, Dewit O, et al. Journal article, Review article Clinical Trial Endpoints for Perianal Fistulizing Crohn's Disease (2026) Reinisch W, Atreya R, Rieder F, Jairath V, Rimola J, Peyrin-Biroulet L, Tozer P, et al. Journal article, Review article Intestinal barrier healing is superior to transmural healing to prevent disease progression in clinical remittent patients with inflammatory bowel disease (2026) Orlemann T, Zimmermann D, Hübner H, Atreya R, Bodenschatz J, Noviello D, Vitali F, et al. Journal article Filamin a binds deleted in liver cancer 1 (DLC1) to promote its tumor suppressor activity and inhibit the SRF coactivator MRTF-A (2026) Sergeev M, Meier M, Wohlleben P, Rupprecht L, Kupraszewicz-Hutzler M, Hilgers KF, Hartner A, et al. Journal article Dual targeting of TNF and IL-23 by a bispecific antibody in ulcerative colitis (2026) Atreya R, Neurath M Journal article JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel disease (2025) Fousekis FS, Jefremow A, Katsanos KH, Neurath M, Atreya R Journal article, Review article Resolving Loss of Response to Ustekinumab in Crohn’s Disease: POWER Through or Switch Treatment? (2025) Noviello D, Atreya R, Noor NM Journal article An international consensus on the design of clinical trials for advanced combination treatment (ACT) in inflammatory bowel disease (2025) Solitano V, Hanžel J, Ma C, Battat R, Raine T, Siegmund B, Peyrin-Biroulet L, et al. Journal article Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis (2025) Ferrante M, Peyrin-Biroulet L, Arkkila P, Armuzzi A, Colombel JF, Danese S, Faggiani R, et al. Journal article CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis (2025) Müller F, Atreya R, Völkl S, Aigner M, Kretschmann S, Kharboutli S, Leppkes M, et al. Journal article